000 | 01756 a2200505 4500 | ||
---|---|---|---|
005 | 20250513205416.0 | ||
264 | 0 | _c20000713 | |
008 | 200007s 0 0 eng d | ||
022 | _a0301-0147 | ||
024 | 7 |
_a10.1159/000022510 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKagawa, H | |
245 | 0 | 0 |
_aEffect of ticlopidine on platelet-derived microparticles in patients with connective tissue diseases. _h[electronic resource] |
260 |
_bHaemostasis _c1999 |
||
300 |
_a255-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntigens, CD _xanalysis |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
650 | 0 | 4 |
_aConnective Tissue Diseases _xblood |
650 | 0 | 4 |
_aEndothelium, Vascular _xchemistry |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinolytic Agents _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xblood |
650 | 0 | 4 |
_aInterleukin-1 _xblood |
650 | 0 | 4 |
_aInterleukin-8 _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPeripheral Vascular Diseases _xblood |
650 | 0 | 4 |
_aPlatelet Activation _xdrug effects |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
650 | 0 | 4 |
_aPlatelet Membrane Glycoproteins _xanalysis |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 |
_aSubcellular Fractions _xdrug effects |
650 | 0 | 4 | _aTetraspanin 30 |
650 | 0 | 4 |
_aTiclopidine _xpharmacology |
650 | 0 | 4 |
_aVascular Cell Adhesion Molecule-1 _xblood |
700 | 1 | _aNomura, S | |
700 | 1 | _aNagahama, M | |
700 | 1 | _aOzaki, Y | |
700 | 1 | _aFukuhara, S | |
773 | 0 |
_tHaemostasis _gvol. 29 _gno. 5 _gp. 255-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000022510 _zAvailable from publisher's website |
999 |
_c10707708 _d10707708 |